Matrices listed below were spiked with certain level of anti-SARS-CoV2(S-RBD)(Delta B.1.617.2)IgA and the recovery rates were calculated by comparing the measured value to the expected amount of anti-SARS-CoV2(S-RBD)(Delta B.1.617.2)IgA in samples.
Matrix
Recovery range(%)
Average(%)
serum(n=5)
91-101
95
EDTA plasma(n=5)
85-96
91
heparin plasma(n=5)
86-101
93
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of anti-SARS-CoV2(S-RBD)(Delta B.1.617.2)IgA and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample
1:2
1:4
1:8
serum(n=5)
89-105%
85-105%
85-105%
EDTA plasma(n=5)
84-99%
83-98%
83-100%
heparin plasma(n=5)
81-90%
88-99%
80-98%
Precision
Intra-Assay: CV<8% Inter-Assay: CV<10%
Notes
For Research Use Only
Applications
ELISA
Applications Notes
anti-SARS-CoV2IgA ELISA Kit allows for the in vitro quantitative determination of anti-SARS-CoV2(S-RBD)(Delta B.1.617.2)IgA concentrations in serum, plasma, tissue homogenates and other biological fluids.
Storage
2-8 °C for 6 months
Reviews of Mouse anti-SARS-CoV2 (S-RBD) (Delta B.1.617.2) IgA ELISA Kit